Is leukoreduction of blood components for everyone?

被引：28

作者：

Corwin, HL

AuBuchon, JP

机构：

[1] Dartmouth Hitchcock Med Ctr, Dept Anesthesiol, Lebanon, NH 03766 USA

[2] Dartmouth Hitchcock Med Ctr, Dept Med, Lebanon, NH 03766 USA

[3] Dartmouth Hitchcock Med Ctr, Dept Pathol, Lebanon, NH 03766 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2003年 / 289卷 / 15期

关键词：

D O I：

10.1001/jama.289.15.1993

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1993 / 1995

页数：3

共 25 条

[1] Safety of the blood supply in the United States: Opportunities and controversies [J].

AuBuchon, JP ;

Birkmeyer, JD ;

Busch, MP .

ANNALS OF INTERNAL MEDICINE, 1997, 127 (10) :904-909

[2] Experience with universal bacterial culturing to detect contamination of apheresis platelet units in a hospital transfusion service [J].

AuBuchon, JP ;

Cooper, LK ;

Leach, MF ;

Zuaro, DE ;

Schwartzman, JD .

TRANSFUSION, 2002, 42 (07) :855-861

[3] A COMPARISON OF FILTERED LEUKOCYTE-REDUCED AND CYTOMEGALOVIRUS (CMV) SERONEGATIVE BLOOD PRODUCTS FOR THE PREVENTION OF TRANSFUSION-ASSOCIATED CMV INFECTION AFTER MARROW TRANSPLANT [J].

BOWDEN, RA ;

SLICHTER, SJ ;

SAYERS, M ;

WEISDORF, D ;

CAYS, M ;

SCHOCH, G ;

BANAJI, M ;

HAAKE, R ;

WELK, K ;

FISHER, L ;

MCCULLOUGH, J ;

MILLER, W .

BLOOD, 1995, 86 (09) :3598-3603

[4]

*DHHS ADV COMM BLO, 2003, BLOODS RES JAN 2001

[5] Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population [J].

Dodd, RY ;

Notari, EP ;

Stramer, SL .

TRANSFUSION, 2002, 42 (08) :975-979

[6] Leukocyte reduction of blood components: Public policy and new technology [J].

Dzik, S ;

Aubuchon, J ;

Jeffries, L ;

Kleinman, S ;

Manno, C ;

Murphy, MF ;

Popovsky, MA ;

Sayers, M ;

Silberstein, LE ;

Slichter, SJ ;

Vamvakas, EC .

TRANSFUSION MEDICINE REVIEWS, 2000, 14 (01) :34-52

[7] A prospective, randomized clinical trial of universal WBC reduction [J].

Dzik, WH ;

Anderson, JK ;

O'Neill, EM ;

Assmann, SF ;

Kalish, LA ;

Stowell, CP .

TRANSFUSION, 2002, 42 (09) :1114-1122

[8]

*FDA BLOOD PROD AD, 2003, 60 M SEPT 18 1998 RO

[9] Clinical outcomes following institution of universal leukoreduction of blood transfusions for premature infants [J].

Fergusson, D ;

Hébert, PC ;

Lee, SK ;

Walker, CR ;

Barrington, KJ ;

Joseph, L ;

Blajchman, MA ;

Shapiro, S .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (15) :1950-1956

[10] Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions [J].

Hébert, PC ;

Fergusson, D ;

Blajchman, MA ;

Wells, GA ;

Kmetic, A ;

Coyle, D ;

Heddle, N ;

Germain, M ;

Goldman, M ;

Toye, B ;

Schweitzer, I ;

vanWalraven, C ;

Devine, D ;

Sher, GD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (15) :1941-1949

← 1 2 3 →